Javascript must be enabled to continue!
α-Synuclein pre-formed fibrils induce prion-like protein aggregation and neurotoxicity in C. elegans models of Parkinson’s disease
View through CrossRef
Abstract
Parkinson’s disease (PD) is a debilitating neurodegenerative disorder characterized by progressive motor decline and the aggregation of α-synuclein protein. Growing evidence suggests that α-synuclein aggregates may spread from neurons of the digestive tract to the brain in a prion-like manner. While rodent models have recapitulated gut-to-brain α-synuclein transmission, animal models that are amenable to high-throughput investigations are needed to facilitate the discovery of disease mechanisms. Here we describe the first
C. elegans
models in which feeding with α-synuclein pre-formed fibrils (PFFs) induced prion-like dopamine neuron degeneration and seeding of aggregation of human α-synuclein expressed in the host. PFF acceleration of α-synuclein aggregation in
C. elegans
muscle cells was associated with a progressive motor deficit, whereas feeding with α-synuclein monomer produced much milder effects. RNAi-mediated knockdown of the
C. elegans
syndecan
sdn-1
, and enzymes involved in heparan sulfate proteoglycan biosynthesis, afforded protection from PFF-induced seeding of aggregation and toxicity, as well as dopaminergic neurodegeneration. This work offers new models by which to investigate gut-derived α-synuclein spreading and propagation of disease.
Title: α-Synuclein pre-formed fibrils induce prion-like protein aggregation and neurotoxicity in
C. elegans
models of Parkinson’s disease
Description:
Abstract
Parkinson’s disease (PD) is a debilitating neurodegenerative disorder characterized by progressive motor decline and the aggregation of α-synuclein protein.
Growing evidence suggests that α-synuclein aggregates may spread from neurons of the digestive tract to the brain in a prion-like manner.
While rodent models have recapitulated gut-to-brain α-synuclein transmission, animal models that are amenable to high-throughput investigations are needed to facilitate the discovery of disease mechanisms.
Here we describe the first
C.
elegans
models in which feeding with α-synuclein pre-formed fibrils (PFFs) induced prion-like dopamine neuron degeneration and seeding of aggregation of human α-synuclein expressed in the host.
PFF acceleration of α-synuclein aggregation in
C.
elegans
muscle cells was associated with a progressive motor deficit, whereas feeding with α-synuclein monomer produced much milder effects.
RNAi-mediated knockdown of the
C.
elegans
syndecan
sdn-1
, and enzymes involved in heparan sulfate proteoglycan biosynthesis, afforded protection from PFF-induced seeding of aggregation and toxicity, as well as dopaminergic neurodegeneration.
This work offers new models by which to investigate gut-derived α-synuclein spreading and propagation of disease.
Related Results
ВОЗМОЖНАЯ РОЛЬ РЕЦЕПТОРОВ ДОФАМИНА DOP-1, DOP-2 И DOP-3 В МОДУЛЯЦИИ ЧУВСТВИТЕЛЬНОСТИ ПОЧВЕННОЙ НЕМАТОДЫ Caenorhabditis elegans К ТОКСИЧЕСКОМУ ДЕЙСТВИЮ ИОНОВ СВИНЦА
ВОЗМОЖНАЯ РОЛЬ РЕЦЕПТОРОВ ДОФАМИНА DOP-1, DOP-2 И DOP-3 В МОДУЛЯЦИИ ЧУВСТВИТЕЛЬНОСТИ ПОЧВЕННОЙ НЕМАТОДЫ Caenorhabditis elegans К ТОКСИЧЕСКОМУ ДЕЙСТВИЮ ИОНОВ СВИНЦА
Проведено изучение возможной роли рецепторов дофамина DOP-1, DOP-2 и DOP-3 в модуляции чувствительности почвенной нематоды Caenorhabditis elegans к токсическому действию нитрата св...
7
th
International Symposium on Enabling Technologies for Life Sciences (ETP)
7
th
International Symposium on Enabling Technologies for Life Sciences (ETP)
The seventh in the series of ETP Symposia (see
Rapid Communications in Mass Spectrometry
2012,
26
, ...
Prion Diseases
Prion Diseases
Abstract
Prion diseases, also known as transmissible spongiform encephalopathies (TSEs), are transmissible degenerative disorders...
Natural genetic variation and an alternative physiological state modify polyglutamine aggregation and toxicity in C. elegans
Natural genetic variation and an alternative physiological state modify polyglutamine aggregation and toxicity in C. elegans
Many human diseases are caused by mutations that induce misfolding and aggregation of the affected proteins, and are thought to result from failures in proteostasis. Pathways invol...
Novel β-synuclein Rearrangements in tumor
Novel β-synuclein Rearrangements in tumor
Abstract
Purpose
The synuclein family includes a-, b-, g-synuclein and is predominantly expressed in neurons. a- and b-synuclein is mutated in Parkinson's disease and demen...
Heparan sulfate proteoglycans mediate prion-like α-synuclein toxicity in Parkinson’s in vivo models
Heparan sulfate proteoglycans mediate prion-like α-synuclein toxicity in Parkinson’s in vivo models
Parkinson’s disease (PD) is a debilitating neurodegenerative disorder characterized by progressive motor decline and the aggregation of α-synuclein protein. Growing evidence sugges...
Protein aggregation, hydrophobicity and neurodegenerative disease
Protein aggregation, hydrophobicity and neurodegenerative disease
In this thesis, we study the relationship between proteins and neurodegenerative disease using different computational and experimental approaches. We focus on two disease mechanis...
p21-activated kinase 4 controls the aggregation of α-synuclein by reducing the monomeric and aggregated forms of α-synuclein: involvement of the E3 ubiquitin ligase NEDD4-1
p21-activated kinase 4 controls the aggregation of α-synuclein by reducing the monomeric and aggregated forms of α-synuclein: involvement of the E3 ubiquitin ligase NEDD4-1
AbstractAggregation of misfolded alpha-synuclein (α-synuclein) is a central player in the pathogenesis of neurodegenerative diseases. Therefore, the regulatory mechanism underlying...

